4/12/2026 最新进展 Recent Progress–>转移性胰腺癌的化疗联合或不联合医学监护生酮饮食的随机II期试验 A randomized phase II trial of chemotherapy with or without a medically supervised ketogenic diet for metastatic pancreatic cancer
4/11/2026 最新进展 Recent Progress–>术后帕博利珠单抗联合belzutifan 用于透明细胞肾细胞癌 Adjuvant pembrolizumab plus belzutifan for clear cell renal cell carcinoma: LITESPARK-022 study
4/5/2026 最新进展 Recent Progress–>超低剂量免疫疗法治疗难治性实体瘤 Ultra-low-dose immunotherapy in refractory solid tumors: DELII trial
4/4/2026 最新进展 Recent Progress–>阿替利珠单抗联合 FOLFOX 治疗 III 期错配修复缺陷型结肠癌 Atezolizumab plus FOLFOX for stage III dMMR colon cancer
3/29/2026 最新进展 Recent Progress–> Odronextamab 联合CHOP 用于初治弥漫大B细胞淋巴瘤 Odronextamab plus CHOP in untreated DLBCL: First results of OLYMPIA-3
3/28/2026 最新进展 Recent Progress–> FDA 批准 Relacorilant 联合纳米炭紫杉醇用于治疗多种铂耐药性妇科肿瘤 Relacorilant with nab-paclitaxel approved for several platinum-resistant gynecologic cancers
3/22/2026 最新进展 Recent Progress–>Tucatinib 联合 Trastuzumab 和 Pertuzumab 对比安慰剂作为 HER2 阳性转移性乳腺癌一线维持治疗 Tucatinib versus placebo in combination ith trastuzumab and pertuzumab as first-line maintenance therapy for HER2+ metastatic breast cancer: HER2CLIMB-05
3/21/2026 最新进展 Recent Progress–>首项 I 期试验针对多发性骨髓瘤的体内 CAR T 细胞疗法 First phase I human study of in vivo CAR T in myeloma
3/15/2026 最新进展 Recent Progress–>消融术与手术治疗T1a期肾细胞癌的长期疗效相当 Ablation and surgery for T1a renal cell carcinoma demonstrate comparable long-term outcomes: A Danish Nationwide Registry Study
3/14/2026 最新进展 Recent Progress–>一种诊断治疗晚期胰腺导管腺癌的新型 KRAS G12D 抑制剂 A novel KRAS G12D inhibitor for advanced pancreatic ductal adenocarcinoma
3/8/2026 最新进展 Recent Progress–>ctDNA 指导肌层浸润性膀胱癌的疗效适应性膀胱保留治疗 ctDNA to guide response-adapted bladder preservation in muscle invasive bladder cancer: RETAIN trials
3/7/2026 最新进展 Recent Progress–>Cadonilimab 治疗复发性宫颈癌 Bispecific cadonilimab in recurrent cervical cancer
3/1/2026 最新进展 Recent Progress–>晚期乳腺癌一线与二线 CDK4/6 抑制剂对总生存期无差别 First-line vs second-line CDK4/6 inhibitor does not impact overall survival in advanced breast cancer: SONIA trial
2/28/2026 最新进展 Recent Progress–>微塑料与前列腺癌 Microplastics and prostate cancer
2/22/2026 最新进展 Recent Progress–>FDA 已批准 amivantamab-vmjw (皮下注射)联合 lazertinib作为一线疗法用于晚期 EGFR突变型非小细胞肺癌 The FDA has approved (subcutaneous) amivantamab-vmjw in combination with lazertinib as a first-line treatment for advanced EGFR-mutant non-small cell lung cancer
2/21/2026 最新进展 Recent Progress–>术前放疗或可改善乳腺癌的抗肿瘤免疫反应 Preoperative radiation may improve antitumor immune response in breast cancer
2/15/2026 最新进展 Recent Progress–>Olaparib monotherapy for metastatic breast cancer with germline mutations in PALB2 or somatic mutations in BRCA1/BRCA2: TBCRC 048 trial
2/14/2026 最新进展 Recent Progress–>溶瘤病毒激活免疫系统对抗胶质母细胞瘤 Oncolytic viruses activate the immune system to treat glioblastoma
2/8/2026 最新进展 Recent Progress–>新型 CDK2抑制剂 INCB123667 用于铂类耐药性卵巢癌 A novel CDK2 inhibitor INCB123667 for platinum-resistant ovarian cancer
2/7/2026 最新进展 Recent Progress–>Zanidatamab 联合化疗±tislelizumab 一线治疗HER2阳性晚期胃食管腺癌 Zanidatamab + chemotherapy ± tislelizumab for first-line HER2-positive locally advanced gastroesophageal adenocarcinoma: HERIZON-GEA-01
2/1/2026 最新进展 Recent Progress–>Imneskibart 联合白介素-2在黑色素瘤和非小细胞肺癌中展现抗肿瘤活性 Imneskibart in combination with interleukin-2 demonstrates antitumor activity in melanoma and non-small cell lung cancer
1/31/2026 最新进展 Recent Progress–>改进用于早期检测胰腺导管腺癌的血浆标志物 Improving a plasma biomarker panel for early detection of pancreatic ductal adenocarcinoma
1/25/2026 最新进展 Recent Progress–>FDA批准Sevabertinib用于非鳞状非小细胞肺癌 FDA approves Sevabertinib for non-squamous non-small cell lung cancer with HER2 TKD activating mutations
1/24/2026 最新进展 Recent Progress–>首创口服小分子PPARγ抑制剂治疗晚期尿路上皮癌 I 期试验 A phase I trial of first-in-class oral small molecule PPARγ inhibitor for the treatment of advanced urothelial carcinoma
1/18/2026 最新进展 Recent Progress–>Zanidatamab联合化疗一线治疗HER2阳性不可切除或转移性胃食管腺癌 Zanidatamab + chemotherapy ± for first-line HER2+ unresectable, or metastatic gastroesophageal adenocarcinoma: HERIZON-GEA-01
1/17/2026 最新进展 Recent Progress–>术前mFOLFIRINOX对比PAXG治疗可切除胰腺导管腺癌 Preoperative mFOLFIRINOX versus PAXG for resectable pancreatic ductal adenocarcinoma: PACT-21 CASSANDRA
1/11/2026 最新进展 Recent Progress–>食品添加剂防腐剂摄入量与癌症发病率 Intake of food additive preservatives and incidence of cancer
1/10/2026 最新进展 Recent Progress–>IgG4 相关疾病患者癌症风险增加 Increased cancer risk in patients with IgG4-related disease in South Korea
1/4/2026 最新进展 Recent Progress–>比较 giredestrant 与标准内分泌疗法作为ER阳性/HER2 阴性早期乳腺癌辅助治疗 Adjuvant therapy using giredestrant vs standard-of-care for ER-positive, HER2-negative early breast cancer: lidERA trial
1/3/2026 最新进展 Recent Progress–>Botensilimab 联合巴斯蒂利单抗联合 balstilimab 治疗难治性卵巢癌患者 Botensilimab plus balstilimab for refractory ovarian cancer